Search
Brimarafenib
go.drugbank.com/drugs/DB21706InvestigationalBrimarafenib has a monoisotopic molecular weight of 482.12 Da. … Brimarafenib is under investigation in clinical trial NCT04249843 (Study of Safety, Pharmacokinetics, and Antitumor Activity of BGB-3245 in Participants with Advanced or Refractory Tumors).
Sulfaguanidine
go.drugbank.com/drugs/DB13726ExperimentalSulfaguanidine is a sulfonamide antibiotic with antimicrobial and antibacterial activities.
Squalamine
go.drugbank.com/drugs/DB06461InvestigationalCategories: Compounds used in a research, industrial, or household settingCyamemazine
go.drugbank.com/drugs/DB09000ExperimentalCyamemazine (Tercian), also known as cyamepromazine, is a typical antipsychotic drug of the phenothiazine class used primarily in the treatment of schizophrenia and psychosis-associated anxiety. … Cyamemazine actually behaves like an atypical antipsychotic, due to its potent anxiolytic effects (5-HT2C) and lack of extrapyramidal side effects (5-HT2A).
Tifcemalimab
go.drugbank.com/drugs/DB18914InvestigationalTifcemalimab is under investigation in clinical trial NCT06095583 (Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell
Talaporfin
go.drugbank.com/drugs/DB11812InvestigationalTalaporfin has been investigated for the treatment of Port-Wine Stain and Benign Prostatic Hyperplasia.
Urocortin-2
go.drugbank.com/drugs/DB13033InvestigationalUrocortin 2 has been investigated for the basic science of Heart Failure and Cardiovascular Disease.
Quinezamide
go.drugbank.com/drugs/DB19459ExperimentalQuinezamide has a monoisotopic molecular weight of 240.1 Da.
Darsidomine
go.drugbank.com/drugs/DB19460ExperimentalDarsidomine has a monoisotopic molecular weight of 196.13 Da.
Mitoclomine
go.drugbank.com/drugs/DB19467ExperimentalMitoclomine has a monoisotopic molecular weight of 311.08 Da.